R J Hurlbert1, R Moulton. 1. Department of Clinical Neurosciences, Foothills Hospital and Medical Centre, Calgary, AB, Canada.
Abstract
OBJECTIVE: To determine the practice patterns for methylprednisolone administration for patients with acute spinal cord injury (SCI) within the spinal surgery community across Canada, and the reasons behind these patterns. METHODS: Canadian neurological and orthopedic spine surgeons were surveyed at their respective annual meetings with a questionnaire asking seven questions with respect to their practice standards. RESULTS: Sixty surgeons completed the survey representing approximately two-thirds of surgeons treating acute SCI within Canada. The NASCIS III dosing regimen is the most commonly prescribed steroid protocol. However, one-quarter of surgeons do not administer steroids at all. Of those who administer methylprednisolone, most do so because of peer pressure or out of fear of litigation. CONCLUSIONS: The vast majority of spine surgeons in Canada either do not prescribe methylprednisolone for acute SCI, or do so for what might be considered the wrong reasons. These results demonstrate the need for an evidence-based practice guideline. The Canadian Spine Society and the Canadian Neurosurgical Society fully endorse the recommendations of the steroid task force (see preceding paper).
OBJECTIVE: To determine the practice patterns for methylprednisolone administration for patients with acute spinal cord injury (SCI) within the spinal surgery community across Canada, and the reasons behind these patterns. METHODS: Canadian neurological and orthopedic spine surgeons were surveyed at their respective annual meetings with a questionnaire asking seven questions with respect to their practice standards. RESULTS: Sixty surgeons completed the survey representing approximately two-thirds of surgeons treating acute SCI within Canada. The NASCIS III dosing regimen is the most commonly prescribed steroid protocol. However, one-quarter of surgeons do not administer steroids at all. Of those who administer methylprednisolone, most do so because of peer pressure or out of fear of litigation. CONCLUSIONS: The vast majority of spine surgeons in Canada either do not prescribe methylprednisolone for acute SCI, or do so for what might be considered the wrong reasons. These results demonstrate the need for an evidence-based practice guideline. The Canadian Spine Society and the Canadian Neurosurgical Society fully endorse the recommendations of the steroid task force (see preceding paper).
Authors: Janine N Pettiford; Jai Bikhchandani; Daniel J Ostlie; Shawn D St Peter; Ronald J Sharp; David Juang Journal: Pediatr Surg Int Date: 2011-10-13 Impact factor: 1.827
Authors: Han Ding; Ang Li; Chao Sun; Jianping Zhang; Jun Shang; Haoshuai Tang; Junjin Li; Min Wang; Xiaohong Kong; Zhijian Wei; Shiqing Feng Journal: Ann Transl Med Date: 2022-09
Authors: Jeffrey A Rihn; David T Anderson; Kathleen Lamb; Peter F Deluca; Ahmed Bata; Paul A Marchetto; Nuno Neves; Alexander R Vaccaro Journal: Sports Med Date: 2009 Impact factor: 11.136
Authors: Bizhan Aarabi; J Marc Simard; Joseph A Kufera; Melvin Alexander; Katie M Zacherl; Stuart E Mirvis; Kathirkamanthan Shanmuganathan; Gary Schwartzbauer; Christopher M Maulucci; Justin Slavin; Khawar Ali; Jennifer Massetti; Howard M Eisenberg Journal: J Neurosurg Spine Date: 2012-07-13
Authors: Dung Hoang Nguyen; Newton Cho; Kajana Satkunendrarajah; James W Austin; Jian Wang; Michael G Fehlings Journal: J Neuroinflammation Date: 2012-09-21 Impact factor: 8.322
Authors: Nathan Evaniew; Vanessa K Noonan; Nader Fallah; Brian K Kwon; Carly S Rivers; Henry Ahn; Christopher S Bailey; Sean D Christie; Daryl R Fourney; R John Hurlbert; A G Linassi; Michael G Fehlings; Marcel F Dvorak Journal: J Neurotrauma Date: 2015-07-17 Impact factor: 5.269